Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. CANADIAN NATIONAL STOCK EXCHANGE
  5. Predictmedix Inc.
  6. News
  7. Summary
    PMED   CA74040L1004

PREDICTMEDIX INC.

(PMED)
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Predictmedix to Present at LD Micro Main Event on October 12, 2021

10/04/2021 EST

TORONTO, ON / ACCESSWIRE / October 4, 2021 / Predictmedix Inc. (CSE:PMED)(OTCQB:PMEDF) ("Predictmedix" or the "Company"), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today announced that management will present at the LD Micro Main Event investor conference taking place October 12-14, 2021 in-person at the Luxe Sunset Bel Air in Los Angeles, California.

Dr. Rahul Kushwah, Chief Operating Officer at Predictmedix is scheduled to host a presentation during the conference as follows and will participate in one-on-one investor meetings throughout the day.

LD Micro Main Event
Date: Tuesday, October 12, 2021
Time: 2:00 p.m. Eastern time (11:00 a.m. Pacific time) - Track 4
Webcast: https://me21.mysequire.com/

A live audio webcast and archive of the event presentation will be available using the link to the conference website above. For more information on the LD Micro Main Event, please contact your conference representative.

About Predictmedix Inc.

Predictmedix (CSE:PMED)(OTCQB:PMEDF) is an emerging provider of rapid health screening and remote patient care solutions globally. The Company's Safe Entry Stations - powered by a proprietary artificial intelligence (AI) - use multispectral cameras to analyze physiological data patterns and predict a variety of health issues including infectious diseases such as COVID-19, impairment by drugs or alcohol, or various mental illnesses. Predictmedix's proprietary remote patient care platform empowers medical professionals with a suite of AI-powered tools to improve patient health outcomes. To learn more, please visit our website at www.Predictmedix.com or follow us on Twitter, Instagram or LinkedIn.

Investor Relations Contact
Lucas A. Zimmerman
MZ Group - MZ North America
949-259-4987
PMEDF@mzgroup.us
www.mzgroup.us

Caution Regarding Forward-Looking Information:

THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED NOR DOES IT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

This news release may contain forward-looking statements and information based on current expectations. These statements should not be read as guarantees of future performance or results of the Company. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management's reasonable assumptions, there can be no assurance that such assumptions will prove to be correct. We assume no responsibility to update or revise them to reflect new events or circumstances. The Company's securities have not been registered under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act"), or applicable state securities laws, and may not be offered or sold to, or for the account or benefit of, persons in the United States or "U.S. Persons", as such term is defined in Regulations under the U.S. Securities Act, absent registration or an applicable exemption from such registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in the United States or any jurisdiction in which such offer, solicitation or sale would be unlawful. Additionally, there are known and unknown risk factors which could cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained herein, such as, but not limited to dependence on obtaining regulatory approvals; the ability to obtain intellectual property rights related to its technology; limited operating history; general business, economic, competitive, political, regulatory and social uncertainties, and in particular, uncertainties related to COVID-19; risks related to factors beyond the control of the company, including risks related to COVID-19; risks related to the Company's shares, including price volatility due to events that may or may not be within such party's control; reliance on management; and the emergency of additional competitors in the industry.

All forward-looking information herein is qualified in its entirety by this cautionary statement, and the Company disclaims any obligation to revise or update any such forward-looking information or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events or developments, except required by law.

The Company is not making any express or implied claims that its product has the ability to diagnose, eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus) at this time.

Disclaimer

PredictMedix Inc. published this content on 04 October 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 October 2021 07:50:04 UTC.


ę Publicnow 2021
All news about PREDICTMEDIX INC.
01/12PREDICTMEDIX : Announces Accuracy Rates for Alcohol and Cannabis Impairment Detection Tech..
PU
2021PREDICTMEDIX : Interim CEO Certificate - Q3 2021
PU
2021PREDICTMEDIX : Interim CFO Certificate - Q3 2021
PU
2021PREDICTMEDIX : Interim Financial Statements - Q3 2021
PU
2021PREDICTMEDIX : Interim MD&A - Q3 2021
PU
2021Predictmedix Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended ..
CI
2021PREDICTMEDIX : Secures Inaugural Placement of Safe Entry Station at Health and Wellness Re..
PU
2021Predictmedix Safe Entry Station Receives CE Mark Approval and ISO Certification for Com..
PU
2021Predictmedix Deploys Safe Entry Stations At Formula 1 Aramco United States Grand Prix
CI
2021Predictmedix Deployed Safe Entry Stations at Formula 1 Aramco United States Grand Prix
PU
More news
Financials
Sales 2021 - - -
Net income 2021 -1,58 M -1,26 M -1,26 M
Net cash 2021 0,48 M 0,38 M 0,38 M
P/E ratio 2021 -17,0x
Yield 2021 -
Capitalization 14,7 M 11,8 M 11,7 M
EV / Sales 2020 -
EV / Sales 2021 -
Nbr of Employees -
Free-Float -
Chart PREDICTMEDIX INC.
Duration : Period :
Predictmedix Inc. Technical Analysis Chart | PMED | CA74040L1004 | MarketScreener
Income Statement Evolution
Managers and Directors
Sheldon Kales President, Chief Executive Officer & Director
Rakesh Malhotra Chief Financial Officer & Secretary
Rahul Kushwah Chief Executive Officer & Director
Ajit Kumar Independent Director
Tomas Sipos Independent Director
Sector and Competitors
1st jan.Capi. (M$)
PREDICTMEDIX INC.-10.00%12
SMC CORPORATION-12.88%39 172
COGNEX CORPORATION-11.46%11 787
SHIMADZU CORPORATION-16.07%10 530
MKS INSTRUMENTS, INC.-7.33%8 952
WUHAN GUIDE INFRARED CO., LTD.-4.87%8 815